secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2022-10-28T23:59:59+00:00
Accession:  0001493152-22-029856
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences reports 2022 annual meeting results; all proposals pass
---------------------------------------------------------------------------

- Annual meeting quorum: 856,447 shares (41.2% of outstanding); all seven director nominees elected, with Joseph Tucker receiving 228,825 votes for.
- Advisory vote on named executive officer compensation passed with 178,176 for, 68,125 against, 1,771 abstain.
- Ratification of Marcum LLP as independent auditor approved with 826,728 for, 27,656 against, 2,063 abstain.
- Broker non-votes totaled 608,375 on director election and advisory proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315222029856/0001493152-22-029856-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315222029856/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-029856

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer